Ana Barac
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 100
- Cardiovascular Function and Risk Factors 20
- Heart Failure Treatment and Management 19
- Cardiac tumors and thrombi 9
- Acute Myocardial Infarction Research 9
- Takotsubo Cardiomyopathy and Associated Phenomena 8
-
- Cardiac Imaging and Diagnostics 42
- Co-authors
- Jorge Silvio Gutkind (4 shared papers)Bonnie Ky (8 shared papers)Susan Faye Dent (10 shared papers)Julio A. Panza (6 shared papers)Umberto Campia (5 shared papers)Lavanya Kondapalli (4 shared papers)Annabelle Santos Volgman (2 shared papers)Marielle Scherrer-Crosbie (8 shared papers)
- Journals
- Journal of the American College of Cardiology (21 papers)JACC CardioOncology (17 papers)European Heart Journal (8 papers)Circulation (8 papers)Breast Cancer Research and Treatment (7 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Ana Barac
198 papers receiving 14.2k citations
Ana Barac's Hit Papers
Peers
Comparison fields: 5 of 140
- Cardiology and Cardiovascular Medicine 9.5k
- Oncology 3.9k
- Radiology, Nuclear Medicine and Imaging 2.5k
- Internal Medicine 172
- Pulmonary and Respiratory Medicine 1.4k
Countries citing papers authored by Ana Barac
This map shows the geographic impact of Ana Barac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Barac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Barac more than expected).
Fields of papers citing papers by Ana Barac
This network shows the impact of papers produced by Ana Barac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Barac. The network helps show where Ana Barac may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Barac, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Hit paper breakdown → | 2022 | 1877 |
| 2 | Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Hit paper breakdown → | 2014 | 1411 |
| 3 | Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Hit paper breakdown → | 2017 | 961 |
| 4 | Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Hit paper breakdown → | 2014 | 821 |
| 5 | Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations Hit paper breakdown → | 2020 | 761 |
| 6 | Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association Hit paper breakdown → | 2018 | 624 |
| 7 | Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society Hit paper breakdown → | 2020 | 573 |
| 8 | Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement Hit paper breakdown → | 2021 | 436 |
| 9 | Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association Hit paper breakdown → | 2019 | 347 |
| 10 | 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Hit paper breakdown → | 2022 | 333 |
| 11 | 2020 | 279 | |
| 12 | Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology Hit paper breakdown → | 2020 | 268 |
| 13 | 2020 | 227 | |
| 14 | 2020 | 220 | |
| 15 | 2004 | 205 | |
| 16 | 2015 | 180 | |
| 17 | 2012 | 174 | |
| 18 | 2018 | 168 | |
| 19 | 2021 | 152 | |
| 20 | 2019 | 151 |
About Ana Barac
Ana Barac is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 207 papers that have together received 14.7k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (100 papers), Cardiac Imaging and Diagnostics (42 papers), Cardiovascular Function and Risk Factors (20 papers), Heart Failure Treatment and Management (19 papers), Cancer Treatment and Pharmacology (17 papers), Cardiac tumors and thrombi (9 papers), Acute Myocardial Infarction Research (9 papers) and Takotsubo Cardiomyopathy and Associated Phenomena (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (9.5k citations), Oncology (3.9k citations), Radiology, Nuclear Medicine and Imaging (2.5k citations), Internal Medicine (172 citations) and Pulmonary and Respiratory Medicine (1.4k citations). Ana Barac has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Jorge Silvio Gutkind, Bonnie Ky, Susan Faye Dent, Julio A. Panza, Umberto Campia, Lavanya Kondapalli, Annabelle Santos Volgman, Marielle Scherrer-Crosbie, Salvador Cruz‐Flores and Vera Bittner. Their work appears in journals such as Journal of the American College of Cardiology, JACC CardioOncology, European Heart Journal, Circulation and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.